Director/PDMR Shareholding

Summary by AI BETAClose X

IP Group plc announced the release of Deferred Bonus Awards on April 22, 2026, resulting in the transfer of 168,957 ordinary shares to executive directors and one other person discharging managerial responsibilities. This release, valued at £107,625.61 based on an aggregated price of 63.7 pence per share, involved a total of 883,427,642 shares in issue with none held in treasury. The transaction facilitated the application of the Group's Post Cessation Shareholding Policy.

Disclaimer*

IP Group PLC
23 April 2026
 

 

FOR RELEASE ON

23 April 2026

 

IP Group plc - Employee Share Schemes; Director/PDMR shareholding

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, announces the following in connection with its employee share schemes.

 

Release of Deferred Bonus Awards

 

On 22 April 2026, the Group's executive directors and one other person discharging managerial responsibilities ("PDMR") received a total of 168,957 ordinary shares of two pence each ("Shares"), resulting from the release of Deferred Bonus Awards granted in relation to the partial deferral of annual bonuses for the 2023 and 2024 financial years. 

 

The delivery of the awards was satisfied through the transfer of Shares from the Company's employee benefit trust (the "EBT"), with the balance being settled by cash payments in an amount sufficient to meet the relevant individuals' income and other tax liabilities in accordance with the rules of the IP Group Share Plan ("Share Plan"). 

The Shares transferred to the Group's executive directors will be held by the EBT on behalf of, and as nominee for, the executive directors in order to facilitate the application of the Group's Post Cessation Shareholding Policy.

 

A copy of the Share Plan can be found at:

https://www.ipgroupplc.com/investors/corporate-governance

 

 

Shares in issue

As at 22 April, the Company had 883,427,642 Shares in issue and no Shares held in treasury.


The following information is being disclosed pursuant to the requirements of MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 

DBA Release

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Greg Smith
David Baynes
Mark Reilly

2

Reason for the notification

a)

Position/status

Director        Chief Executive Officer
Director        Chief Operating and Financial Officer
PDMR          Managing Partner

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 
ISIN: GB00B128J450

b)

Nature of the transaction

Release of the 2024 Deferred Bonus Awards and 2025 Deferred Bonus Awards

c)

Currency

GBP

d)

Price(s) and volume(s)

Name(s)

Price(s)

Volume(s)

Greg Smith

Conditional Share Award

67,116

David Baynes

Conditional Share Award

41,435

Mark Reilly

Conditional Share Award

60,406

e)

Aggregated information

-Aggregated volume

- Price

- Aggregated total

 

168,957

 

63.7p

£107,625.61

f)

Date of the transaction

22 April 2026

g)

Place of the transaction

London Stock Exchange, Main Market

 

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com


Liz Vaughan-Adams, Communications   

 

Portland

 

 

Alex Donaldson


+44 (0) 20 7444 0062/+44 (0) 7979 853802

 

 

 

+44 (0) 7516 729702

 

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science and technology investor, we develop and support some of the world's most exciting businesses in healthtech, deeptech and cleantech. Including through Parkwalk, the UK's largest growth EIS fund manager, we back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, Hinge Health, Featurespace, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

IP Group (IPO)
UK 100

Latest directors dealings